QUALITY CONCERNS AND ACCESSIBILITY ISSUES: GENERIC MEDICINES AND COMPULSORY LICENSING IN INDIA

Read full text Summarise with VIRAT
Authors: Shiv Shankar Singh, Mrs. Shreya
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Despite India's reputation as the global manufacturer of generic drugs, a huge quality concern persists in India and generic medicines are assumed as low quality drugs compared to the branded options. Due to high prices, many citizens in India are deprived from various essential and life saving drugs. This deprivation has also been enhancing due to quality concerns and accessibility issues in the generic alternatives of the branded drugs. The authors have tried to find out whether there are enough legal standards and experts’ backing in India to confirm that generic medicines are as effective as the branded drugs and lower prices of the generic medicines are not associated with poor drug quality or do not indicate that there is lack of essential ingredients in the manufacturing of generic drugs to make them affordable. Essentially, the authors have analysed whether low cost generic medicines are really an affordable option of the costly branded drugs or not. At the end various suggestions have also been given to eradicate the quality concerns in the generic medicines and to enhance their accessibility.

Fields of Study & Subjects

Pharmaceutical Economics and Policy Pharmaceutical Quality and Counterfeiting Healthcare Regulation

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
25 March 2026
Language
EN